Himachal Pradesh high court restrains DRL from selling BI’s diabetic drug Jardiance

Dr Reddy’s on Thursday said Himachal Pradesh high court has issued an interim injunction restraining them from manufacturing and selling generic version of German drug maker Boehringer Ingelheim‘s (BI) diabetes drug Jardiance.

The drugmaker said it is reviewing legal options including filing an appeal against the court order.

Dr Reddy’s has launched copies of Jardiance (empagliflozin), which has valid patent in India until 2025. BI has sought restraining order on manufacture and sale of the drug.

Jardiance is top-selling drug for BI in India.

  • Related Posts

    8 Women Develop Complications Post C-Section, 2 Critical

    Close on the heels of maternal deaths and kidney-related complications reported in Kota and Bikaner following caesarean deliveries, a similar case has surfaced at Paota District Hospital in Jodhpur, where…

    Kota District In-Charge Secretary Directs Implementation of Risk Management Framework in Hospitals; Emphasis on SOPs and Infection Control

    Jaipur/Kota— In a significant move to strengthen patient safety and improve healthcare delivery in government hospitals, Kota district in-charge secretary Dr. Ravi Kumar Surpur has directed the immediate preparation and effective…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    8 Women Develop Complications Post C-Section, 2 Critical

    8 Women Develop Complications Post C-Section, 2 Critical

    Kota District In-Charge Secretary Directs Implementation of Risk Management Framework in Hospitals; Emphasis on SOPs and Infection Control

    Kota District In-Charge Secretary Directs Implementation of Risk Management Framework in Hospitals; Emphasis on SOPs and Infection Control

    Probe report into maternal deaths sparks Kota row

    Probe report into maternal deaths sparks Kota row

    Centre bans 16 Fixed-Dose Combination drugs over safety concerns

    Centre bans 16 Fixed-Dose Combination drugs over safety concerns

    Maha FDA seizes medicines worth Rs 9.09 lakh from Mumbai children’s hospital over alleged illegal sale

    Maha FDA seizes medicines worth Rs 9.09 lakh from Mumbai children’s hospital over alleged illegal sale

    CDSCO constitutes consultancy committee for advice on suo motu disclosure

    CDSCO constitutes consultancy committee for advice on suo motu disclosure